2^nd Experts Meeting on Cancer Medicine, Radiology & Treatment October 25-26, 2023 Paris, France

DR Jehad Zweiri, lecturer in Cancer studies at the University of Liverpool Medical School, born and grew up in Jordan and received his Bachelor’s degree from the University of Jordan. He obtained his master degree from London School of Hygiene and Tropical Medicine/University of London, and then obtained his PhD degree in 2000 from Kings College Medical School/University of London, in the field of Immune Gene Therapy of Cancer under the supervision of Professor Farzin Farzaneh. He then started his work as Postdoctoral Associate at the department of Immunology and Medicine at the University of Liverpool in 2002. In 2010 he was appointed as a lecturer in the University of Liverpool Medical School and he is currently fellow of the British Higher Education Academy since 2012.

1) Inflammation: Acute inflammation is a defense process whereas chronic inflammation is a disease process. 2) Hyper secretion of mucus: is the result of goblet cell hyperplasia in respiratory mucosa and is a prominent future of inflammation. They go together. Chronic mucus hyper secretion is a potential risk factor for an accelerated loss of lung function. The thick viscous mucus in the lungs will be conducive to pathogens. Currently available medicines and methods are not able to meet the needs of the sufferers. Continued inflammation and mucus hyper secretion may significantly contribute to transformation of normal cells into cancer cells i.e. the scope for series of mutations on Genes may get increased. 3) Bronchospasm: is an additional factor in asthma patients.

Surgeon Paik was born in Iksan, Jeonbuk, Korea. He graduated from Seoul National University College of Medicine, ther after served as director of Korea Cancer Center Hospital, director of Konkuk University Medical Center, chairman of Korean Breast Cancer Society and chairman of Asia Breast Cancer Society. In 1986, he became the first surgeon to carry out breast-conserving surgery (BCS) in Korea. In 1991, he developed ‘Paik Nam-sun Stomach Cancer Surgery’ that reduces the risk of reflux oesophagitis. Such achievements earned him a spot on a list of the world’s top 100 gastric and breast cancer surgeons, unveiled by the international Biographical Center of Cambridge in the UK in 2006. He is unequivocally the No.1 breast cancer specialist in and outside Korea. 출처 : Korea IT Times(http://www.koreaittimes.com)

“The sufferings of breast cancer patients do not end after surgery. Breast cancer survivors, who had to have their breasts removed or disfigured, cannot go to public bathhouses or get divorced by their husbands. Their heartbreaking stories had prompted me to focus on breast-conserving surgery,” said breast cancer specialist Paik Nam-sun, Director of the Ewha Womans University Cancer Center for Women (hereafter EWUCCW).

Dr Mari Aparici, MD is a Clinical Professor at Stanford University. She is a Nuclear Physician with residencies in both Europe (Barcelona) and US (Stanford), and with Molecular imaging fellowships from Stanford University. She is a physician-scientist in the development of Molecular Imaging. She has more than 20 years of clinical and research experience in the field, more than 10 years of a leadership position as Chief Nuclear Medicine at the San Francisco VAMC as part of her prior appointment as a UCSF faculty member, and now as Head of the Theranostics and Nuclear Therapies program at Stanford University. She has published more than 100 papers in reputed journals, has been serving as an editorial board member of reputed journals, has been PI of NIH and non-NIH grants and serves as a member of several to committees at her University and several Societies.

Clinical Focus on Radiology & Nuclear Medicine

Dimitrios H. Roukos, MD, PhD, is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. Following conventional surgical oncology research, he has shifted into interpatient heterogeneity-based Personalized Cancer Medicine combining clinico-pathologic and single gene characteristics. Recently, he is exclusively focusing on intratumor multi-regional and even single-cell genetic, genomic, transcriptional and regulatory network heterogeneity-based drug resistance and relapse towards future clinical Precision Oncology. He has developed and published 3 breakthrough concepts to overcome clinical unmet needs. He has published > 240 PubMed papers, 36 on Precision Medicine and Oncology, and 80 on static and spatiotemporal genome analysis with NGS. These publications have received more than 9000 citations with h-index: 75 (Scopus). He is reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Italy, Belgium, Luxemburg, Poland), member in the editorial board of 25 international journals with IF, as well as Organizing Committee member and Invited lectures in > 130 International Conferences.

Precision Cancer Medicine,Cancer Diagnostics,Cancer Biomarkers

Claude Prigent has completed his PhD at the age of 30 years from Rennes University in France and postdoctoral studies from Imperial Cancer research Fund, Clare Hall Lab in London, UK. He is the director of research in the CNRS : National Center for Scientific Research in Freance. He has published more than 110 papers in reputed journals.

Cancer Cell Biology

Jana Slobodnikova. M.D., end study on Charles University in Prague., gradued - CSc / PhD / completed at the age 38 years from Institus of Experimental Oncology Slovac Scientic Academy. Ass. Prof. in 43 years from Trnaviensis University, Prof. emeritus at age 45 years from St. Elizabeth High Scool. I have lectured at several universities - Prague, Tren?ín, Trnava and Bratislava. I am the author of teaching script, university textbooks, I lead workshops, I organize international congresses and worksops Her has published more than 90 scientific papers, from then 25 papers in renomed journals and has been serving as an 5 editorial board member of repute. Her has published 3 monography, Her founded the Section of Breast Imaging in 1996, from 1996 her is president The Section of Breast Imaging of Slovak radiologic Society and vice president The Slovak Society of Ultrasound in Medicine. Membership in organizations : ECR, EUSOBI, EFSUMB , SSUM ( Slovak Society of Ultrasound in Medicine ) and SRS ( Slovak Radiology Society).

Radiology, Diagnosis of breast cancer, Screening, Radiology in oncology, Diagnosis and treatment of complications after breast spectrum of laboratory examination methods in Oncology, Tumor markers, Immunohistochemistry, biopsy surgery, treatment and diagnosis of lymphedema